Perinatal pathologies serve as the basis for a great variety of diseases in teenagers and adults including the especially frequent and important diseases of the nervous system which is vulnerable during the period of ante- and early postnatal development, especially against the background of genetic predisposition to it. This leads to development of pathology also manifesting at later stages of life. In this connection, the review presents molecular and genetic predictors of endothelial dysfunction and impairment of angio- and neurogenesis during the perinatal period. The article presents facts related to the influence of endothelial dysfunction as a trigger for pregnancy pathology and fetal-programmed diseases. A discussion regarding the contribution made by the congenital and by the acquired into basic mechanisms of fetal development including the brain and its pathologies
Th is literature review addresses a number of modern concepts of aetiopathogenetic mechanisms in placental dysfunction and their role in development of CNS pathology in the foetus. A complex analysis of literature data has made it possible to understand the complexity and multifaceted nature of placental disorders modulating brain development from the moment of trophoblast implantation. Th e eff ects of prenatal factors on the foetus are limited to the protective function of the placenta retaining the placental reserve. Nevertheless, gestation pathology beginning from embryogenesis defi nes genetic and epigenetic impairments confi rming the concept of the placenta being “the third brain” connected to the maternal brain and the foetus’s developing brain and conditioning the severity of hypoxic-ischaemic injury and the nature of further neurological impairments. Th e review has been written based on analysis of literatures presented in eLIBRARY.RU, Cyberleninka, PubMed, ScienceDirect and Web of Science databases published in 2005-2021 (predominantly within the past 5-7 years) using the following keywords: molecular and genetic predictors, preeclampsia, angiogenesis, neurogenesis, vascular endothelial growth factor and VEGF.
25 September 2020 in Medical Herald of the South of Russia
A clinical case of congenital hyperinsulinism, diffuse form, pharmacoresistant course (heterozygous mutation of p. 1361 1363 dup CGG in the GCK gene) in an early child is presented as an example of an orphan severe disease with an extremely unfavorable course and a probability of deterioration of the long-term prognosis. The goal was to highlight the clinical manifestations, course options, and complexity of treatment of this pathology to a wide range of doctors of different specialties in the field of Pediatrics in terms of improving the quality and timeliness of diagnosis, reducing the number of complications with the formation of irreparable consequences. Attention is drawn to the most severe course of hypoglycemic conditions in the early neonatal period, the dependence of the formation of a pronounced neurological deficit on the degree and duration of hypoglycemia, which emphasizes the importance of their timely correction to preserve the quality of life of this contingent of children.
15 February 2021 in Pediatria. Journal named after G.N. Speransky
Erythropoietin is recognized as a pluripotent glycoprotein with unique biochemical and epigenetic properties that are important for fetal growth and development, as well as in critical conditions in subsequent periods of ontogenesis. In recent decades, researchers and clinicians have increased interest in the problem of the biological significance of erythropoietin, which can form the basis for constructing algorithms for early prognosis and diagnosis, optimizing the treatment of pathology of the perinatal period, including perinatal hypoxic-ischemic damage to the brain and spinal cord, which are at risk of disability and have a risk of disability significant role in neonatology and perinatal neurology.
20 December 2020 in Medical Herald of the South of Russia
Glutaric aciduria type I (deficiency of glutaryl-COA dehydrogenase, glutaric acidemia type I) is a rare autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl – COA - dehydrogenase (GCDH). Cerebral organic aciduria, caused by a deficiency of glutaryl-COA - dehydrogenase, is generally considered a neurological disorder.The phenotypic spectrum of untreated GA-1 varies from a more common and pronounced form (a disease with infancy) to a low-symptom and less common form. In people with the same genotype, the clinical manifestations and depth of CNS damage can vary widely depending on the age of manifestation of acute encephalopathic crises. It is assumed that with early detection and treatment of “asymptomatic” newborns (in the context of screening for this disease), most people who would have developed manifestations of GA-1 with childhood or late onset will remain asymptomatic.